Collagenase Activating Factor in Brain Tumors
Author Information
Author(s): C.M. Taylor, J.B. Weiss, R.H. Lye
Primary Institution: University of Manchester
Hypothesis
Do raised levels of ESAF correlate with tumor malignancy and growth activity?
Conclusion
Intracranial tumors have higher levels of ESAF compared to normal brain tissue, especially in actively growing tumors.
Supporting Evidence
- ESAF levels were significantly higher in malignant tumors compared to benign tumors.
- Actively growing tumors had ESAF concentrations considerably greater than control brain samples.
- Only gliomas contained significantly more ESAF than control brain samples.
Takeaway
This study found that a special factor called ESAF is more common in brain tumors that are growing quickly compared to those that are not.
Methodology
Biopsy samples from patients were analyzed for ESAF levels using histological examination and various biochemical assays.
Limitations
The study had a small sample size and short clinical follow-up, limiting the ability to correlate ESAF levels with patient survival.
Participant Demographics
Patients with benign or malignant intracranial tumors, aged 24 to 82.
Statistical Information
P-Value
0.025
Statistical Significance
p=0.025
Want to read the original?
Access the complete publication on the publisher's website